| BTG Share Price | |||
|---|---|---|---|
| Price | 125.50 | Open | 126.00 |
| Bid | 124.50 | High | 126.50 |
| Ask | 125.50 | Low | 125.00 |
| Change | -2.00 (-1.57%) | Close | 127.50 |
| Volume | 205,614 | ||
| Currency | GBX |
|---|---|
| Issue Country | GB |
| Shares in Issue | 161.11m |
| Market Cap | £202.19m |
| PE Ratio | 31.375 |
| EPS | 4.00 |
| Year High | 129.00 |
|---|---|
| Year High Date | 09-Jun-2026 |
| Year Low | 106.00 |
| Year Low Date | 23-Oct-2025 |
| Dividend | 4.00 |
| Yield | 3.187% |
| # Trades | 52 |
|---|---|
| Vol. Sold | 40,394 |
| Sold Value | £50.97k |
| Vol. Bought | 100,257 |
| Bought Value | £126.24k |
| Market Size | 3,000 |
| Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
|---|---|---|---|---|---|---|---|---|
| 12-Jun-26 | 16:35:25 | 125.50 | 2,959 | Buy* | 124.50 | 125.50 | 3,714 | A Automatic Execution |
| 12-Jun-26 | 16:35:25 | 125.50 | 3,826 | Buy* | 124.50 | 125.50 | 4,802 | UT Uncrossing Trade |
| 12-Jun-26 | 16:27:32 | 125.50 | 7,000 | Buy* | 124.50 | 125.50 | 8,785 | A Automatic Execution |
| 12-Jun-26 | 16:27:25 | 125.50 | 5,000 | Buy* | 124.50 | 125.50 | 6,275 | O Ordinary |
| 12-Jun-26 | 16:27:18 | 125.0073 | 5,000 | Buy* | 124.50 | 125.50 | 6,250 | O Ordinary |
| 12-Jun-26 | 16:15:09 | 125.41 | 2,054 | Buy* | 124.50 | 125.50 | 2,576 | O Ordinary |
| 12-Jun-26 | 15:46:06 | 125.41 | 856 | Buy* | 124.50 | 125.50 | 1,074 | O Ordinary |
| 12-Jun-26 | 15:33:41 | 125.50 | 1 | Buy* | 124.50 | 125.50 | 1.26 | O Ordinary Trade was executed as an SI |
| 12-Jun-26 | 15:33:41 | 125.00 | 4 | Unknown* | 124.50 | 125.50 | 5.00 | O Ordinary Trade was executed as an SI |
| 12-Jun-26 | 15:33:41 | 125.00 | 6 | Sell* | 124.50 | 125.50 | 7.50 | A Automatic Execution |
| Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
|---|---|---|---|---|---|---|---|
| 01-Apr-26 | 31-Mar-26 | Transfer To | Richard W Traynor held the position of Executive Chairman at the time of this trade.Richard W Traynor | 0.00 | 3 | 27,178,977 | |
| 16-Aug-19 | 16-Aug-19 | Buy | Duncan Kennedy held the position of CFO at the time of this trade.Duncan Kennedy | 565.07 | GBX | 1,061 | 298,135 |
| 16-Aug-19 | 16-Aug-19 | Exercise of Option | Dame Pamela Louise Makin held the position of CEO at the time of this trade.Dame Pamela Louise Makin | 0.00 | 474,861 | 2,251,917 | |
| 16-Aug-19 | 16-Aug-19 | Exercise of Option | Dame Pamela Louise Makin held the position of CEO at the time of this trade.Dame Pamela Louise Makin | 565.07 | GBX | 1,274 | 2,251,917 |
| 16-Aug-19 | 16-Aug-19 | Exercise of Option | Duncan Kennedy held the position of CFO at the time of this trade.Duncan Kennedy | 0.00 | 45,910 | 298,135 |
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.